David Degen - Publications

Affiliations: 
2013 Rutgers University, New Brunswick, New Brunswick, NJ, United States 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Anwar AF, Cain CF, Garza MJ, Degen D, Ebright RH, Del Valle JR. Stabilizing pseudouridimycin: Synthesis, RNA-polymerase inhibitory activity, and antibacterial activity of dipeptide-modified analogues. Chemmedchem. e202300474. PMID 37751316 DOI: 10.1002/cmdc.202300474  0.664
2022 Elbatrawi YM, Gerrein T, Anwar A, Makwana KM, Degen D, Ebright RH, Del Valle JR. Total Synthesis of Pargamicin A. Organic Letters. PMID 36516292 DOI: 10.1021/acs.orglett.2c03861  0.541
2022 Hassan HM, Degen D, Jang KH, Ebright RH, Fenical W. Correction to: Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. The Journal of Antibiotics. PMID 35546183 DOI: 10.1038/s41429-022-00528-4  0.613
2019 Lin W, Mandal S, Degen D, Cho MS, Feng Y, Das K, Ebright RH. Structural basis of ECF-σ-factor-dependent transcription initiation. Nature Communications. 10: 710. PMID 30755604 DOI: 10.1038/s41467-019-08443-3  0.725
2019 Lin W, Mandal S, Degen D, Cho, Feng Y, Das K, Ebright RH. Structural basis of ECF-sigma-factor-dependent transcription initiation. Nature Communications. 10: 710-710. DOI: 10.2210/Pdb6Dv9/Pdb  0.753
2018 Lin W, Das K, Degen D, Mazumder A, Duchi D, Wang D, Ebright YW, Ebright RY, Sineva E, Gigliotti M, Srivastava A, Mandal S, Jiang Y, Liu Y, Yin R, et al. Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3). Molecular Cell. PMID 29606590 DOI: 10.1016/J.Molcel.2018.02.026  0.688
2017 Maffioli SI, Zhang Y, Degen D, Carzaniga T, Del Gatto G, Serina S, Monciardini P, Mazzetti C, Guglierame P, Candiani G, Chiriac AI, Facchetti G, Kaltofen P, Sahl HG, Dehò G, et al. Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase. Cell. 169: 1240-1248.e23. PMID 28622509 DOI: 10.1016/J.Cell.2017.05.042  0.713
2017 Lin W, Mandal S, Degen D, Liu Y, Ebright YW, Li S, Feng Y, Zhang Y, Mandal S, Jiang Y, Liu S, Gigliotti M, Talaue M, Connell N, Das K, et al. Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. Molecular Cell. PMID 28392175 DOI: 10.1016/J.Molcel.2017.03.001  0.797
2017 Walker SS, Degen D, Nickbarg E, Carr D, Soriano A, Mandal MB, Painter RE, Sheth PR, Xiao L, Sher X, Murgolo N, Su J, Olsen DB, Ebright RH, Young K. Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor. Acs Chemical Biology. PMID 28323406 DOI: 10.1021/Acschembio.6B01133  0.686
2015 Feng Y, Degen D, Wang X, Gigliotti M, Liu S, Zhang Y, Das D, Michalchuk T, Ebright YW, Talaue M, Connell N, Ebright RH. Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. Structure (London, England : 1993). PMID 26190576 DOI: 10.1016/J.Str.2015.06.009  0.751
2015 Hassan HM, Degen D, Jang KH, Ebright RH, Fenical W. Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. The Journal of Antibiotics. 68: 206-9. PMID 25227504 DOI: 10.1038/Ja.2014.122  0.649
2015 Feng Y, Degen D, Wang X, Gigliotti M, Liu S, Zhang Y, Das D, Michalchuk T, Ebright YW, Talaue M, Connell N, Ebright RH. Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles Structure. DOI: 10.1016/j.str.2015.06.009  0.621
2014 Tang W, Liu S, Degen D, Ebright RH, Prusov EV. Synthesis and evaluation of novel analogues of ripostatins. Chemistry (Weinheim An Der Bergstrasse, Germany). 20: 12310-9. PMID 25112727 DOI: 10.1002/Chem.201403176  0.638
2014 Degen D, Feng Y, Zhang Y, Ebright KY, Ebright YW, Gigliotti M, Vahedian-Movahed H, Mandal S, Talaue M, Connell N, Arnold E, Fenical W, Ebright RH. Transcription inhibition by the depsipeptide antibiotic salinamide A. Elife. 3: e02451. PMID 24843001 DOI: 10.7554/Elife.02451  0.808
2014 Zhang Y, Degen D, Ho MX, Sineva E, Ebright KY, Ebright YW, Mekler V, Vahedian-Movahed H, Feng Y, Yin R, Tuske S, Irschik H, Jansen R, Maffioli S, Donadio S, et al. GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides. Elife. 3: e02450. PMID 24755292 DOI: 10.7554/Elife.02450  0.775
2012 Srivastava A, Degen D, Ebright YW, Ebright RH. Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56: 6250-5. PMID 23006749 DOI: 10.1128/Aac.01060-12  0.609
2011 Srivastava A, Talaue M, Liu S, Degen D, Ebright RY, Sineva E, Chakraborty A, Druzhinin SY, Chatterjee S, Mukhopadhyay J, Ebright YW, Zozula A, Shen J, Sengupta S, Niedfeldt RR, et al. New target for inhibition of bacterial RNA polymerase: 'switch region'. Current Opinion in Microbiology. 14: 532-43. PMID 21862392 DOI: 10.1016/J.Mib.2011.07.030  0.639
Show low-probability matches.